NICO

NICO enrolls first patient in phase III hemorrhagic stroke trial

Wednesday, January 11, 2017

Indianapolis Medical device maker NICO has announced the enrollment of the first patient in the ENRICH (Early MiNimally-invasive Removal of ICH) randomized clinical trial. This trial is designed to determine the procedural safety, as well as the economic and functional benefit, of early surgical removal of intracerebral hemorrhage using the BrainPath Approachä compared to the medical management standard of care. The BrainPath Approach uses a combination of technologies, including the FDA-cleared NICO BrainPath for non-disruptive access and NICO Myriad to achieve the goal of maximum clot evacuation.

[Read More]